BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update : vimarsana.com

Conference call planned for early April 2024 to provide update on NurOwn program
NEW YORK, April 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell...

Related Keywords

California , United States , Stacy Lindborg , Chaim Lebovits , Lisa Guiterman , Michael Wood , Research Symposium , Drug Administration , European Medicines Agency , California Institute For Regenerative Medicine , Nasdaq , National Ms Society , Brainstorm Cell Therapeutics Inc , Gene Therapies Advisory Committee , Brainstorm Cell Therapeutics , Biologics License Application , Chief Executive Officer , Special Protocol Assessment , Scientific Conference , Executive Vice President , Chief Development Officer , Biological License Application , Year Ended December , Storm Cell Therapeutics , Orphan Drug , California Institute , Regenerative Medicine , Regarding Forward Looking Statements , Term Assets , Term Liabilities , Markets ,